aripiprazole has been researched along with Emesis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Açıkel, B; Hergüner, S; Yar, A | 1 |
Cantrell, FL; Clark, RF; Shah, N; Young, MC | 1 |
Assuncao-Talbott, S; Blumer, J; Boulton, DW; Findling, RL; Iwamoto, T; Kauffman, R; Kollia, G; Kornhauser, DM; Mallikaarjun, S; McQuade, RD; Sahasrabudhe, V; Salazar, DE; Sallee, FR; Vachharajani, NN | 1 |
Ebrecht, M; Kungel, M; Messer, T; Modell, S; Schmauss, M; Spevakne-Goeroecs, T; Werner, C | 1 |
Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL | 1 |
Inoue, T; Kurokawa, K; Nakamura, A; Narita, M; Shiokawa, M; Suzuki, T | 1 |
2 trial(s) available for aripiprazole and Emesis
Article | Year |
---|---|
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Germany; Humans; Male; Nausea; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Sleep Initiation and Maintenance Disorders; Vomiting | 2010 |
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting | 2007 |
4 other study(ies) available for aripiprazole and Emesis
Article | Year |
---|---|
Functional Vomiting Treated Successfully with Aripiprazole in a Child with Autism Spectrum Disorder.
Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Male; Treatment Outcome; Vomiting | 2016 |
Risk assessment of isolated aripiprazole exposures and toxicities: a retrospective study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Infant; Male; Middle Aged; Nausea; Piperazines; Poison Control Centers; Poisoning; Quinolones; Retrospective Studies; Risk Assessment; Tachycardia, Sinus; Vomiting; Young Adult | 2009 |
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Child; Conduct Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Quinolones; Tremor; Vomiting | 2009 |
Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis.
Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Aripiprazole; Ferrets; Male; Morphine; Piperazines; Quinolones; Receptors, Dopamine D2; Vomiting | 2007 |